HIV, HCV and HBV : A Review of Parallels and Differences
Elimination of the three blood-borne viruses-human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV)-as public health issues may be plausible in the near future. Spectacular advances have been made with the introduction of highly effective antiviral agents into clinical practice, and prevention strategies are available for all three infections. Effective disease control, laid out by WHO global strategies, is currently feasible for all three viruses. However, for worldwide elimination of these viruses, effective vaccines are required that are currently only available for HBV. In this review differences and parallels among HIV, HCV and HBV will be discussed with a focus on virologic and therapeutic issues, and prospects for the future of HBV will be presented.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Infectious diseases and therapy - 7(2018), 4 vom: 04. Dez., Seite 407-419 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Leoni, Maria C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antiviral therapy |
|---|
| Anmerkungen: |
Date Revised 21.04.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s40121-018-0210-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM288198778 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM288198778 | ||
| 003 | DE-627 | ||
| 005 | 20231225055727.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40121-018-0210-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0960.xml |
| 035 | |a (DE-627)NLM288198778 | ||
| 035 | |a (NLM)30182282 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Leoni, Maria C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HIV, HCV and HBV |b A Review of Parallels and Differences |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Elimination of the three blood-borne viruses-human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV)-as public health issues may be plausible in the near future. Spectacular advances have been made with the introduction of highly effective antiviral agents into clinical practice, and prevention strategies are available for all three infections. Effective disease control, laid out by WHO global strategies, is currently feasible for all three viruses. However, for worldwide elimination of these viruses, effective vaccines are required that are currently only available for HBV. In this review differences and parallels among HIV, HCV and HBV will be discussed with a focus on virologic and therapeutic issues, and prospects for the future of HBV will be presented | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Antiviral therapy | |
| 650 | 4 | |a Elimination | |
| 650 | 4 | |a HIV virus | |
| 650 | 4 | |a Hepatitis B virus | |
| 650 | 4 | |a Hepatitis C virus | |
| 650 | 4 | |a Vaccination | |
| 700 | 1 | |a Ustianowski, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Farooq, Hamzah |e verfasserin |4 aut | |
| 700 | 1 | |a Arends, Joop E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infectious diseases and therapy |d 2012 |g 7(2018), 4 vom: 04. Dez., Seite 407-419 |w (DE-627)NLM240483693 |x 2193-8229 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2018 |g number:4 |g day:04 |g month:12 |g pages:407-419 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40121-018-0210-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2018 |e 4 |b 04 |c 12 |h 407-419 | ||